COVID-19 Travel Testing

24-Hour RT-PCR Test

No appointment necessary.
You must register prior to testing

Test results: 24 hours from arrival at laboratory* – NOT from test specimen collection

Test price: $150

At KSL Diagnostics, we understand COVID-19 travel testing requires urgent and special attention to ensure your test results are valid when traveling across state lines or to another country. To assist you with your travel testing needs:

  • Acceptable for most travel requirements—know your travel requirements prior to testing. KSL Diagnostics does NOT take responsibility for travel testing requirements beyond providing test results in 24 hours or less*

  • Meets requirement for NAAT (nucleic acid amplification test)

  • Specimens are collected by oropharyngeal (oral), nasopharyngeal, or anterior nares swab, according to your travel needs

  • Payment required at time of testing—no prescription/insurance billing

  • For more information on KSL Diagnostics test pricing and policies, see below or call 1-800-960-1080 to speak with a representative.

  • Send your specific travel testing questions to — we regularly monitor this account and will respond promptly

*24-Hour RT-PCR test results are expected to be reported within one day. In rare instances, more time may be required. Inconclusive results may require collection of a new sample. While KSL Diagnostics will make every effort to provide test results within one day, there are no guarantees and any refunds will be given at our discretion.


Looking for prescription testing for return to school and other medically necessary, insurance-billable reasons?

Frequently Asked Questions

What is a COVID-19 RT-PCR test?

  • A COVID-19 RT-PCR test detects RNA that is unique to the SARS-CoV-2 virus. The specimen for this testing is generally collected using a oropharyngeal swab unless a nasopharyngeal swab is requested. COVID-19 virus test results are positive during infection (asymptomatic or symptomatic) and negative for individuals who have not been infected as well as in individuals who have been infected but whose immune system has effectively cleared the virus.

What is RT-PCR?

  • RT-PCR stands for Reverse Transcription Polymerase Chain Reaction, a laboratory method used to detect specific RNA sequences. This is a high sensitivity laboratory method that utilizes polymerase to amplify specific genetic targets. Amplification is monitored and indicative of the presence of the target if amplification is successful.

What is SARS-CoV-2?

  • SARS-CoV-2 is the abbreviation for Severe Acute Respiratory Syndrome Coronavirus 2, the virus that causes Coronavirus disease-2019, also known as COVID-19 or novel coronavirus disease.

What can my COVID-19 test results tell me?

  • A positive PCR test indicates the presence of SARS-CoV-2 virus.

Does insurance cover this test?

  • Insurance will generally cover testing for patients with suspected COVID-19 exposure and symptoms consistent with COVID-19, or patients requiring a test for surgical procedures. Insurance will generally NOT cover for all other COVID-19 testing needs—including travel and elective COVID-19 testing. Insurance does not cover 24-hour RT-PCR testing for travel or rapid antigen testing.

Are these tests approved by FDA?

  • The COVID-19 tests currently offered by KSL are approved by FDA through Emergency Use Authorization (EUA).

Significance of this test:


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously called 2019-nCoV) belongs to the family of coronaviruses and, like SARS-CoV, is classified in the genus Betacoronavirus [1]. The new coronavirus originated in China in the city of Wuhan, Hubei province. It caused an infection wave, which has spread rapidly within the country and worldwide [2, 3]. Just a few days after the first report about patients with pneumonia of unclear origin, the causative pathogen was identified as SARS-CoV-2 [2-4]. SARS-CoV-2 is predominantly transmitted by droplet infection via coughing or sneezing and through close contact with infected patients [2, 3, 5].


The incubation time of SARS-CoV is three to seven, maximally 14 days [2]. The symptoms of SARS-CoV-2 infection are fever, coughing, breathing difficulties and fatigue [2, 3, 5]. In most patients the infection manifests with symptoms of a mild febrile illness with irregular lung infiltrates. Some patients, especially elderly or chronically ill patients, develop severe acute respiratory distress syndrome (ARDS). The disease is fatal in around 3% of cases [2, 3, 5]. In February 2020, the disease caused by SARS-CoV-2 was named COVID-19 by the WHO.


COVID-19 RT-PCR test is a reverse transcription polymerase chain reaction test to detect SARS-CoV-2, the virus that causes COVID-19.



  1. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv preprint. doi: 10.1101/2020.02.07.937862

  2. Wang G, Jin X. The progress of 2019 Novel Coronavirus (2019-nCoV) event in China. J MedVirol. doi: 10.1002/jmv.25705

  3. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses 2020, 12(2), 135

  4. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3): pii=2000045

  5. Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring. J Med Virol. 2020; 1-4